Bristol-Myers Squibb Company
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $20.32B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $981.3M | 4.8% |
| Business Acquisitions | $17.16B | 84.4% |
| Other | $2.18B | 10.7% |
| Net Cash Flow | $0 | 0.0% |